A briefing for America’s leading employers
The largest hidden cost in your workforce. And almost no one is treating it.
Inside your own claims data sits a multi-billion-dollar line item, alcohol and substance use disorder, undercounted by roughly ten to one.
It quietly drives absenteeism, turnover, safety incidents, and the cost of nearly every other condition it touches. It is the single largest hidden, addressable healthcare cost in your workforce, and the first employer to treat it will lead the country.
You have led every category you entered. This is the one still open.
The organizations that set the standard, in logistics, in technology, in how a modern workforce is supported, tend to move the country with them. When you decide something matters, the country follows. One category is still waiting for that leadership.
It is the largest hidden, addressable healthcare cost in your workforce, greater in dollar impact than almost any benefit decision you have made, and no employer has truly solved it. Not because it cannot be solved, but because almost no one has been willing to look directly at it.
The first employer to treat substance use as the medical and financial problem it is will lead the country, and capture the largest health-cost opportunity available to it today.
Every employer manages this reactively. Almost none manage it well.
Employees struggle in silence
Most never raise their hand. Families don’t know where to turn, and the people closest to the problem are the last to hear about it.
Managers aren’t equipped to help
Care is fragmented, hard to find, and harder to navigate. Good intentions run into a system no one built for this.
Stigma keeps it hidden
Fear of exposure and judgment keeps people quiet until something breaks, long after the moment help would have mattered most.
Employers engage only after a crisis
An ER visit. A failed test. A leave of absence. A resignation. By then the cost is already paid, and the hardest one to recover.
“Call us when it becomes an emergency.”
No one would wait for cancer to become an emergency before treating it. Yet that is precisely how substance health is managed today, for millions of working people.
This is not a wellness perk. It is workforce reliability.
Every large operator runs on the same fundamentals, attendance, performance, safety, cost, and retention. Untreated substance use moves every one of them the wrong way, and it shows up in your operations long before it ever shows up as a diagnosis.
Sources: National Safety Council; NorthStar claims analysis.
What your claims can’t see is roughly ten times what it shows.
This is not a data error. It is structural. Clinicians are trained to avoid recording substance use as the primary diagnosis, so the condition disappears into the conditions it drives. Your reporting shows a fraction of the people actually affected.
Across every employer population we have analyzed, true prevalence has tracked closely to National Safety Council benchmarks.
people affected in a workforce of one million covered lives, and largely invisible to you today.
Source: National Safety Council; NorthStar population analysis.
The country is watching the wrong epidemic.
Alcohol use disorder is roughly ten times more prevalent than opioid use disorder, and takes more American lives every year. It draws a fraction of the attention because it is hidden in plain sight.
of adults with a substance use disorder are employed. This is a workforce problem first, and yours specifically.
saved per employee supported through effective treatment, via lower medical cost, fewer missed days, and reduced turnover.
Sources: NIAAA · CDC · National Safety Council.
Twenty years. Hidden in plain sight.
For twenty years, alcohol was the one thing that never let her down. It started during a divorce, one beer, then two, then a bottle of wine after the kids were asleep. She drank in secret. Twenty-five drinks a day. Her family tells her now, “We always knew.”
“I could have died. I would have bled out in the middle of the night and not woken up.”
A fever. An ambulance. An emergency scan. Even in the hospital bed, the condition kept bargaining. Amy is not a statistic. She is one of millions, and many of them are on your payroll right now.
A NorthStar patient. Shared with permission.
A multi-billion-dollar line item. And that is only the floor.
Directly attributable to alcohol & substance use disorder. How we get there: 1,000,000 covered lives × 17–25% prevalence × ~$10,500 excess claims per affected member ($15,000 affected vs $4,500 unaffected).
In a real 20,000-employee population we analyzed, 24% carried a definitive AUD/SUD diagnosis, roughly $52 million in excess spend traced to a single underlying condition the claims data was hiding.
Modeled, and built to be confirmed against your own claims · ODG 2023; NorthStar claims analysis (CPT-coded).
When alcohol use disorder co-occurs, the cost of everything else multiplies.
Average payer cost when AUD co-occurs with a condition, versus the same diagnosis without it (ODG, 2023). The darker the tile, the greater the amplification, and the deeper the cost is buried inside something else.
Source: Official Disability Guidelines (ODG), 2023.
You may believe this is already covered. It is not.
Most large employers have layered in mental-health and wellbeing benefits, and at the earliest, mildest stage of substance use they can help. But that is the entire reach. These tools are low-touch by design, a coach, an app, a handful of sessions, usually built around a single substance, and they falter well before mid-stage. They were never made to treat the moderate-to-severe substance use disorder that drives nearly all of the cost.
- •Early, stage-one substance use
- •Typically a single substance
- •Mild, low-acuity support
- •And rarely effective even one stage further
- →Mid-stage to severe AUD / SUD
- →Poly-substance and complex cases
- →Medication matched to a person’s biology
- →Integrated addiction psychiatry
- →Sustained, year-long medical care with a measurable outcome
Your most expensive, highest-risk members are the ones with the least appropriate care.
Addiction treatment hasn’t changed in a hundred years.
Every other field of medicine has been remade by a century of science. Addiction care still does what it did in 1925, it sends people to a 28-day facility, an acute intervention for a chronic condition, then sends them home and waits. Most people cycle through it five or more times.
Failed treatment is the most expensive treatment there is.
Sources: JAMA / NIH addiction literature (Kelly et al., 2019); industry episode pricing.
There is a model built for exactly the part no one is treating.
Not willpower. Not a 28-day event. A physician-built, genetics-led, year-long medical program delivered entirely at home, designed to treat the biology of addiction, not just the behavior, and to close every gap the current system leaves open. People keep their jobs, their families, and their privacy while they get well.
Matched to biology
Care guided by a person’s own genetics, not trial and error across months of guessing.
A full year, at home
Continuous medical support across the whole year. No leave of absence. No disappearance.
Accountable
A measurable outcomes commitment, tracked the entire way, the opposite of paid-regardless-of-result.
“You would never tell someone with cancer to just stop having cancer.”
Every measure moved the right way. And the gains held.
6.6× traditional rehab.
vs ~50% who drop out of the legacy model.
Post-treatment member survey.
Statistically significant gains.
This model is NorthStar. The how is the next conversation.
Source: NorthStar December 2025 Validated Outcomes Report.
Start with your own numbers.
The crisis is national, almost entirely hidden, and sitting in your own claims data right now. Before any decision, before any commitment, we will size the affected population inside your workforce, at no cost. We run our CPT-coded methodology on your own claims and show you exactly how many of your people are affected, what they cost today, and where. The case rests on your numbers, not ours.
Size your population
A no-cost, CPT-coded analysis of your own claims. See how many of your people are affected, what they cost today, and where the spend is buried.
Request your analysisRequest a working session
One executive briefing to walk your team through the model, the evidence, and the economics, and to open the population where care can begin now.
Book a briefing
Where every number comes from.
Covered lives × prevalence × excess claims; pending your claims data.
Prevalence, % employed, absenteeism, presenteeism, incidents, turnover, per-employee savings.
CPT-coded, real 20,000-employee population: claims visibility, excess claims, $52M.
Official Disability Guidelines: comorbidity cost amplification.
Return to use (~86%), lasting success (~13%), average attempts (~5.4, Kelly et al.), dropout.
Alcohol prevalence vs opioids; alcohol-attributable deaths.
$55,000–$62,000 per 28-day inpatient episode.
Sustained success, retention, NPS, clinical instruments, p<.001.
Full citations and underlying methodology available on request. Modeled figures are directional and will be validated against your own claims during the cohort-sizing step.